Immunotherapy of prostate cancer: should we be targeting stem cells and EMT? - sprookjes - yvandenbroek - TriplyDB

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

http://www.wikidata.org/entity/Q37891875

about

Prostate Cancer Stem Cells: Research Advances Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer TIM-3 expression in human osteosarcoma: Correlation with the expression of epithelial-mesenchymal transition-specific biomarkers Immunotherapy targeting glioma stem cells--insights and perspectives.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review.Therapeutic antibodies against cancer stem cells: a promising approach.Controlling the dynamics of cell transition in heterogeneous cultures using surface chemistry.Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Increased CCL19 expression is associated with progression in cervical cancer.

P2860

Q26998435-5C466A58-67B3-43A7-B98E-93508E0AA82A Q28084851-BB23DCF6-1FCA-4D8C-AD20-3B230585CE2C Q37211620-3BE89E78-30D1-4C80-832E-31A2EFD78691 Q37971408-AD6B1B4F-A48C-43B4-8B14-7B29AAA317F2 Q38023238-789FA84F-02A0-4338-A3E9-7B7477D42C2D Q38209356-7F4E6FC6-5A8E-4F63-AE09-D4DF9B1B64CC Q38637435-93B92F07-B8E6-48DA-9309-719C8A0222C1 Q38940778-36783F85-8672-4155-BC45-3AAA02B31760 Q39093352-2371C638-D7EB-4315-80A3-888864729A37 Q47135591-8663E619-DF12-4196-9281-D007CE5E1BFB

P2860

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

http://www.wikidata.org/entity/Q37891875

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@en

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@nl

type

label

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@en

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@nl

prefLabel

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@en

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@nl

P1433

Q37891875-817EB25E-DF0E-44BE-94FC-5173D04353E7

P1476

Q37891875-3F2F739D-5CA2-4BF1-8779-26CDD0683DB3

P2093

Q37891875-4B8A8C8C-06F5-4CA3-A97F-3AE7C3A64186

Q37891875-55621315-D946-4AAC-9457-040B69A1DCC9

Q37891875-C85ACAAF-7992-4E88-8CDD-D0952C4947E9

P2860

Q37891875-00364C76-F14B-4430-BF38-BCC862B2DACC

Q37891875-02A1CD8D-756D-492F-BE3A-D27DFE140A0A

Q37891875-02BD2D21-5B82-44E6-AE35-0E20D24323D9

Q37891875-06C0C650-D0BC-4AB9-9F2C-8E7458074ABF

Q37891875-106E36C2-6510-4F4A-8DB9-1D95E4D5830A

Q37891875-10CCD646-C7ED-4CC1-A639-AACC6E8C9A91

Q37891875-1220E5B5-1098-42F4-86F8-28FB7A7DE5B8

Q37891875-14AE7565-9366-4A88-AB61-E28F81A4CF82

Q37891875-16215135-C375-44D9-8F5C-AB72B875AEC3

Q37891875-184CBB4E-9D80-491E-B419-E7A834DF4A70

P2888

Q37891875-786BA334-435E-468D-BE01-3C3EF4DF7EC0

P304

Q37891875-A2F90EC6-88AE-419F-A2E2-D2CB5ACC49B5

P31

Q37891875-85FB0259-9E41-4D7B-B457-797663DFA43C

P356

Q37891875-8FC677A2-E9FB-4417-826D-22186F4272A1

P433

Q37891875-DAF6015C-FB13-4E34-873C-AA55D86C096A

P478

Q37891875-9720DC83-C368-4A48-BF11-4632461C6037

P50

Q37891875-EF401740-3E63-4F1E-B008-90F859C5EB83

P577

Q37891875-B4691580-6227-488E-8BC3-D5B0E51415A3

P698

Q37891875-543F09A3-4B3C-46D6-815B-912F7D89B717

P921

Q37891875-B46A0C06-9427-4D35-8F1D-A4B6F8A33E7E

P356

S00262-011-1065-8

P1433

Cancer Immunology, Immunotherapy

P1476

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

@en

P2093

Naomi L Dunning

http://www.w3.org/2001/XMLSchema#string

Robert C Rees

http://www.w3.org/2001/XMLSchema#string

Stéphanie A Laversin

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

Twist is a potential oncogene that inhibits apoptosis

Identification of cells initiating human melanomas

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Stem cells, cancer, and cancer stem cells

P2888

s00262-011-1065-8

P304

1181-1193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-011-1065-8

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Amanda K. Miles

P577

2011-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21688178

http://www.w3.org/2001/XMLSchema#string

P921